A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis
What it found
The trial ended early for another reason (see below).
Reason given: NIH did not fund the study so it never started
What was tested
Treatment tested
- Testosterone
Androgen Receptor agonist
Placebo or sham
- placebo gel
What it measured
Main measures
Whole Brain Atrophy
96 weeks
Brain volume loss
Who could take part
MS (type not specified) · 18 to 60
Inclusion Criteria: Men, aged 18-60, with a diagnosis of multiple sclerosis by 2010 revised McDonald Criteria
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This is a multicenter, prospective, placebo-controlled, double-blind randomized Phase II clinical trial assessing the effect of testosterone treatment vs. placebo treatment for 96 weeks duration on whole brain atrophy in men with MS.
Loading reviews and guidelines…
Related trials
- Multiple Sclerosis, menopause and hormone replacement the…
Phase 4 · Completed
No result found
- Oral Testosterone for Fatigue in Male Multiple Sclerosis …
Phase 2 · Stopped early
Stopped early
- POPART`MUS
Phase 3 · Ongoing
Still running
History
Main results due
Jan 2099
Finished
Jan 2099
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error